Cost-effectiveness analysis of a kidney and cardiovascular disease treatment program in an Australian Aboriginal population

Baker, Philip R., Hoy, Wendy E., & Thomas, Roger E. (2005) Cost-effectiveness analysis of a kidney and cardiovascular disease treatment program in an Australian Aboriginal population. Advances in Chronic Kidney Disease, 12(1), pp. 23-31.

View at publisher

Abstract

The objective of the study was to assess, from a health service perspective, whether a systematic program to modify kidney and cardiovascular disease reduced the costs of treating end-stage kidney failure. The participants in the study were 1,800 aboriginal adults with hypertension, diabetes with microalbuminuria or overt albuminuria, and overt albuminuria, living on two islands in the Northern Territory of Australia during 1995 to 2000. Perindopril was the primary treatment agent, and other medications were also used to control blood pressure. Control of glucose and lipid levels were attempted, and health education was offered. Evaluation of program resource use and costs for follow-up periods was done at 3 and 4.7 years. On an intention-to-treat basis, the number of dialysis starts and dialysis-years avoided were estimated by comparing the fate of the treatment group with that of historical control subjects, matched for disease severity, who were followed in the before the treatment program began. For the first three years, an estimated 11.6 person-years of dialysis were avoided, and over 4.7 years, 27.7 person-years of dialysis were avoided. The net cost of the program was 1,210 dollars more per person per year than status quo care, and dialyses avoided gave net savings of 1.0 million dollars at 3 years and 3.4 million dollars at 4.6 years. The treatment program provided significant health benefit and impressive cost savings in dialysis avoided.

Impact and interest:

22 citations in Scopus
Search Google Scholar™
19 citations in Web of Science®

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 55739
Item Type: Journal Article
Refereed: Yes
Additional Information: Cited By (since 1996): 16
Export Date: 13 December 2012
Source: Scopus
Keywords: Angiotensin-converting enzyme inhibitors, antihypertensive agents, cardiovascular diseases, chronic kidney failure, cost-benefit analysis, oceanic ancestry group
DOI: 10.1053/j.ackd.2004.10.001
ISSN: 1548-5609
Subjects: Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > CARDIOVASCULAR MEDICINE AND HAEMATOLOGY (110200)
Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > CLINICAL SCIENCES (110300)
Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > PUBLIC HEALTH AND HEALTH SERVICES (111700) > Aboriginal and Torres Strait Islander Health (111701)
Australian and New Zealand Standard Research Classification > ECONOMICS (140000) > OTHER ECONOMICS (149900) > Economics not elsewhere classified (149999)
Divisions: Current > QUT Faculties and Divisions > Faculty of Health
Current > Schools > School of Public Health & Social Work
Deposited On: 12 Mar 2013 06:04
Last Modified: 22 Mar 2013 05:53

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page